Stocks · Health care · Biological Products, (No Diagnostic Substances)

Gilead Sciences

GILD Clue Score57
United States Fiscal year ends December CIK 0000882095 Results filed 29 Oct 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Merdad Parsey
13 Mar 2023
Chief Medical Officer
Sell
6,126
$78.99
$483.89K
Merdad Parsey
1 Mar 2023
Chief Medical Officer
Sell
12,984
$79.96
$1.04M
Merdad Parsey
30 Dec 2022
Chief Medical Officer
Sell
553
$85.33
$47.19K
Brett A Pletcher
11 Mar 2022
EVP,Corp Affairs & Gen Counsel
Sell
3,634
$58.24
$211.64K
Brett A Pletcher
9 Feb 2022
EVP,Corp Affairs & Gen Counsel
Sell
1,691
$63.89
$108.04K
Brett A Pletcher
1 Feb 2022
EVP,Corp Affairs & Gen Counsel
Sell
14,061
$68.54
$963.68K
Johanna Mercier
4 May 2021
Chief Commercial Officer
Sell
19,496
$66.09
$1.29M
Brett A Pletcher
11 Mar 2021
EVP,Corp Affairs & Gen Counsel
Sell
1,486
$63.36
$94.15K
Brett A Pletcher
10 Feb 2021
EVP,Corp Affairs & Gen Counsel
Sell
1,975
$67.41
$133.13K
Brett A Pletcher
1 Feb 2021
EVP,Corp Affairs & Gen Counsel
Sell
9,711
$65.97
$640.63K
Merdad Parsey
17 Aug 2020
Chief Medical Officer
Sell
182
$68.32
$12.43K
Javier Rodriguez
23 Jun 2020
Director
Sell
189
$75.50
$14.27K
Brett A Pletcher
2 Mar 2020
EVP,Corp Affairs & Gen Counsel
Sell
1,100
$71.26
$78.38K
Brett A Pletcher
2 Mar 2020
EVP,Corp Affairs & Gen Counsel
Sell
9,341
$70.83
$661.63K
Brett A Pletcher
7 Feb 2020
EVP,Corp Affairs & Gen Counsel
Sell
1,426
$70.00
$99.82K
Brett A Pletcher
5 Nov 2019
EVP,Corp Affairs & Gen Counsel
Sell
2,095
$66.06
$138.40K
Brett A Pletcher
28 Oct 2019
EVP, Gen Counsel & Corp Sec
Sell
5,677
$63.31
$359.41K
Brett A Pletcher
19 Aug 2019
EVP, Gen Counsel & Corp Sec
Sell
608
$64.35
$39.12K
Brett A Pletcher
18 Jun 2019
EVP, Gen Counsel & Corp Sec
Sell
5,816
$68.75
$399.85K
Showing 250 of 316 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 665
Amendments (4/A) skipped 2
Filings about a different issuer 15
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 95
Sales straight out of an exercise 187
Sales at will 26
Transactions with no price 0
Shares from compensation/vesting 9,649,606
Sales filed before the plan box existed 26
History held since 29 Sep 2006